lobbying_activities: 2340743

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2340743	54c6cef0-6f8b-4a7e-844a-c837c482fe14	Q3	MCDERMOTT+ LLC	401103287	CAMPAIGN FOR SUSTAINABLE DRUG PRICING	2019	third_quarter	MMM	Issues relating to prescription drug pricing HHS Rebate Rule Medicare Part D benefit re-design H.R. 2113 - Prescription Drug STAR Act S. 551 - Recovering Excessive Funds for Unused and Needless Drugs (REFUND) Act H.R. 3 - Lower Drug Costs Now Act of 2019 S. 2543 - Prescription Drug Pricing Reduction Act of 2019	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2019-10-11T14:31:55.327000-04:00